Synergistic Deposition of C4d by Complement‐Activating and Non‐activating Antibodies in Cardiac Transplants
Open Access
- 9 October 2007
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 7 (11) , 2605-2614
- https://doi.org/10.1111/j.1600-6143.2007.01971.x
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathwayTransplant Immunology, 2006
- Incidence of C4d Stain in Protocol Biopsies from Renal Allografts: Results from a Multicenter TrialAmerican Journal of Transplantation, 2005
- Detection and specification of noncomplement binding anti-HLA alloantibodiesHuman Immunology, 2004
- Complement activation in early protocol kidney graft biopsies after living-donor transplantation1Transplantation, 2003
- Mechanism for in vitro “accommodation” of human aortic endothelial cells by alloantibodies specific for HLA molecules: down regulation of adhesion molecules and over expression of protective genesHuman Immunology, 2002
- Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejectionNephrology Dialysis Transplantation, 2001
- IgG Fc ReceptorsAnnual Review of Immunology, 2001
- Human IgG Fc receptor heterogeneity: molecular aspects and clinical implicationsImmunology Today, 1993
- Vascular deposition of complement-split products in kidney allografts with cell-mediated rejectionClinical and Experimental Immunology, 1991
- REJECTION OF MURINE CARDIAC ALLOGRAFTSTransplantation, 1986